×
China Pharma Holdings Net Profit Margin 2010-2025 | CPHI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
China Pharma Holdings net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
China Pharma Holdings Net Profit Margin 2010-2025 | CPHI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
China Pharma Holdings net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$18.7B
Dr Reddy's Laboratories (RDY)
$12B
BridgeBio Pharma (BBIO)
$8.7B
Bausch Health Cos (BHC)
$2.4B
Supernus Pharmaceuticals (SUPN)
$1.8B
Amphastar Pharmaceuticals (AMPH)
$1B
Personalis (PSNL)
$568M
Taysha Gene Therapies (TSHA)
$565M
Assembly Biosciences (ASMB)
$143M
Sol-Gel Technologies (SLGL)
$26M
Evoke Pharma (EVOK)
$7M
Teligent (TLGT)
$0M